Drug‐induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitals
- 8 January 2018
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 48 (5) , 549-555
Abstract
Background: Drug‐induced liver injury (DILI) can be associated with certain cutaneous adverse drug reaction (cADR).Aims: To demonstrate the prevalence of DILI in patients with cADRs. Severity and patterns of liver injury, risk factors, causal medications and outcomes are also examined.Methods: A retrospective cohort study of patients with cADRs was conducted across two hospitals in Australia. Patients were identified through cross‐linkage of multiple databases.Results: One hundred and four patients with cADRs were identified. Of these, 33 (31.7%) had liver injury, representing 50% of patients with drug reaction with eosinophilia and systemic symptoms, and 30.2% of patients with Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). Most cases of liver injury (69.7%) were of a cholestatic/mixed pattern with severe disease in 18.2%. No significant risk factors for development of liver injury were noted, but peripheral lymphocytosis may represent a risk in patients with SJS (odds ratio, OR = 6.0, 95% confidence interval, CI: 1.8–19.7, P = 0.003). Antimicrobials were the most common class to be implicated in DILI. The median length of inpatient stay was longer in patients with liver injury compared to those without (19 vs 11 days, P = 0.002). The mortality rate in those with liver injury was 15.2% and 9.9% in those without. No patients required liver transplantation.Conclusions: DILI commonly occurs in patients with cADRs and is associated with longer inpatient stay. Patients with SJS/TEN and peripheral lymphocytosis appear to be at higher risk for developing associated liver injury.Keywords
This publication has 26 references indexed in Scilit:
- Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR studyBritish Journal of Dermatology, 2013
- Characteristics of liver injury in drug-induced systemic hypersensitivity reactionsJournal of the American Academy of Dermatology, 2013
- Anemia in Critical Illness: Insights into Etiology, Consequences, and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011Hepatology, 2012
- Causality assessment methods in drug induced liver injury: Strengths and weaknessesJournal of Hepatology, 2011
- The DRESS Syndrome: A Literature ReviewThe American Journal of Medicine, 2011
- Sepsis-induced cholestasisHepatology, 2007
- Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cellsJournal of Allergy and Clinical Immunology, 2004
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuriesJournal of Clinical Epidemiology, 1993